Autopsy report · NCT02661646

Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device (PCD)

“Due to slow enrollment during COVID”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 7 years 2 months before it stopped.
• 249 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Tactile Medical

Sponsor type

Industry

Conditions

Lymphedema

Interventions

Advanced Pneumatic Compression Device

Participants

249

Sites

6

Countries

United States

Trials that died the same way

• Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
  “Enrollment slower than anticipated and interrupted by COVID-19 pandemic” (84% match in meaning)
• The Impact of Nebivolol Versus Metoprolol on Quality of Life
  “due to slow enrollment” (84% match in meaning)
• Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab
  “Due to enrollment difficulties compounded by the COVID pandemic.” (81% match in meaning)
• A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC
  “Slow enrollment.” (79% match in meaning)
• Proton Radiation Therapy for Pituitary Adenoma
  “Due to slow enrollment and feasibility issues.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.